Across TCGA pan-cancer cohorts, BAALC RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated BAALC data layer compared with 3 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BAALC RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BAALC expression acts as an unfavorable survival marker, although some lineages such as SKCM and LGG show a favorable association.
BLCA, UVM, and UCS are the cancer types where BAALC RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.